Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients

Transplantation

Volumn 76, Issue 11, 2003, Pages 1573-1577

  Covic, Adrian ^a   Goldsmith, D J A ^b   Gusbeth Tatomir, P ^a   Buhaescu, I ^a   Covic, M ^a  

^a C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLYCERYL TRINITRATE; NITRIC OXIDE; SALBUTAMOL;

ADULT; AORTA; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESSENTIAL HYPERTENSION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL; PULSE WAVE; SURVIVAL; TONOMETRY;

ADULT; AORTA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FAMILY; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 0346218092     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000086343.32903.A8     Document Type: Article

References (38)

1. Blacher J, Pannier B, Guerin AP, et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570.
2. Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434.
3. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938.
4. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735.
5. Blacher J, Safar ME, Pannier B, et al. Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens 2002; 11: 629.
6. Covic A, Goldsmith DJ, Panaghiu L, et al. Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. Kidney Int 2000; 57: 2634.
7. Nakanishi T, Ishigami Y, Otaki Y, et al. Impairment of vascular responses to reactive hyperemia and nitric oxide in chronic renal failure. Nephron 2002; 92: 529.
8. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383.
9. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: Methodology and clinical applications. Br J Clin Pharmacol 2001; 52: 631.
10. Wilkinson IB, Hall IR, MacCallum H, et al. Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147.
11. Kasiske BL, Snyder J, Matas A, et al. The impact of transplantation on survival with kidney failure. Clin Transplant 2000; 43: 135.
12. Goldsmith DJ, Covic A. Coronary artery disease in uremia: Etiology, diagnosis, and therapy. Kidney Int 2001; 60: 2059.
13. Chowienczyk PJ, Kelly RP, MacCallum H, et al. Photoplethysmographic assessment of pulse wave reflection: Blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999; 34: 2007.
14. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932.
15. Wilkinson IB, Fuchs SA, Jansen IM, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16: 2079.
16. Savage MT, Ferro CJ, Pinder SJ, et al. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond) 2002; 103: 59.
17. Kelly RP, Millasseau SC, Ritter JM, et al. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001; 37: 1429.
18. Covic A, Goldsmith DJ, Georgescu G, et al. Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 1996; 45: 104.
19. Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768.
20. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17(suppl 1): 29.
21. Woo YM, McLean D, Kavanagh D, et al. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation. J Nephrol 2002; 15: 380.
22. Sahagun-Sanchez G, Espinola-Zavaleta N, Lafragua-Contreras M, et al. The effect of kidney transplant on cardiac function: An echocardiographic perspective. Echocardiography 2001; 18: 457.
23. Mitsnefes MM, Schwartz SM, Daniels SR, et al. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 2001; 5: 279.
24. Suwelack B, Gerhardt U, Hausberg M, et al. Comparison of quinapril versus atenolol: Effects on blood pressure and cardiac mass after renal transplantation. Am J Cardiol 2000; 86: 583.
25. Rigatto C, Foley RN, Kent GM, et al. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 2000; 70: 570.
26. Hernandez D, Lacalzada J, Salido E, et al. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: Role of ACE gene polymorphism. Kidney Int 2000; 58: 889.
27. Midtvedt K, Ihlen H, Hartmann A, et al. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: A prospective randomized double-blind study. Transplantation 2001; 72: 107.
28. Goldsmith D, MacGinley R, Smith A, et al. How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure? Nephrol Dial Transplant 2002; 17: 965.
29. Tycho Vuurmans JL, Boer WH, Bos WJ, et al. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 2002; 13: 177.
30. Hausberg M, Kisters K, Kosch M, et al. Alterations of the arterial vessel wall in renal failure. Med Klin 2000; 95: 279.
31. Zoccali C, Mallamaci F, Maas R, et al. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 2002; 62: 339.
32. Adams MR, Robinson J, Sorensen KE, et al. Normal ranges for brachial artery flow-mediated dilatation: A non-invasive ultrasound test of arterial endothelial function. J Vasc Invest 1996; 2: 146.
33. Thambyrajah J, Landray MJ, McGlynn FJ, et al. Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000; 83: 205.
34. Annuk M, Zilmer M, Lind L, et al. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001; 12: 2747.
35. Asberg A, Midtvedt K, Vassbotn T, et al. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. Nephrol Dial Transplant 2001; 16: 1465.
36. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 1998; 53: 1068.
37. Hausberg M, Kosch M, Stam F, et al. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation. Kidney Int 2001; 59: 1473.
38. Morris ST, McMurray JJ, Rodger RS, et al. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000; 57: 1100.